Financial Performance Highlights

FY2026 Consolidated Results:

  • Revenue: ₹161.68 crore, representing 67% year-on-year growth from ₹96.6 crore in FY2025
  • Profit After Tax: ₹12.3 crore, a tenfold increase from ₹1.1 crore in FY2025
  • Operating Cash Flow: ₹6.1 crore (positive), a significant improvement from negative operating cash flow in FY2025
  • Cash Equivalents: Increased to approximately ₹3.5 crore
  • Net Worth: Increased to approximately ₹199 crore

Operational and Strategic Updates

Business Segment Performance:

  • Healthcare business currently contributes 22% of consolidated revenue
  • Retail business remains a significant revenue contributor providing stability and recurring cash generation
  • Bahrain operations provide strategic value through regional relationships and healthcare talent pool access
  • Education segment supports healthcare network through optometry and healthcare training initiatives

Strategic Transformation:

  • Company has evolved from legacy training/consulting to diversified platform spanning retail, healthcare, and education
  • Healthcare emerging as primary long-term growth and profitability driver
  • Existing facilities across Kerala and Chennai showed improved utilization levels, expanding doctor relationships, and increasing procedure intensity

Management Commentary and Outlook

Growth Strategy:

  • Primary objective: Increase healthcare contribution within overall business mix
  • Medium-term target: Healthcare to contribute 70-80% of revenue (currently 22%)
  • EBITDA margin target: 18-20% in coming years (2026-2029)
  • Growth through organic expansion, capacity optimization, strategic partnerships, and selective acquisitions
  • Focus on deeper integration of healthcare delivery, education, optical services, and talent development

Capital Allocation:

  • Estimated capital requirement: ₹50 crore for future expansions
  • Funding alternatives still under evaluation
  • Priority: Investment in healthcare platform expansion, capacity enhancement, and clinical capabilities
  • Maintain disciplined approach to capital allocation and balance sheet management

Cash Flow Focus:

  • Positive operating cash flow of ₹6.1 crore viewed as major milestone
  • Focus on improving cash conversion, collections, and working capital efficiency
  • Trade receivables increased due to healthcare platform scaling and TPA/institutional settlement cycles

Question & Answer Highlights

Revenue Mix Expectations: Management indicated healthcare currently at 22% revenue contribution with strategic focus to increase this significantly over medium term, though specific FY2027/2028 targets were not quantified.

Capex Plans: Estimated ₹50 crore capital requirement for future expansions, with funding alternatives still being evaluated. Priority given to healthcare segment expansion and selective acquisitions.

Growth Sustainability: Management confident due to below-potential utilization levels at existing facilities, opportunities for additional clinics, specialty services expansion, and international patient growth.

Margin Targets: Targeting 18-20% EBITDA margins in coming years (2026-2029), compared to current ~15% operating profit in hospital segment.